Nautilus Biotechnolgy

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAUT and other ETFs, options, and stocks.

About NAUT

Nautilus Biotechnology, Inc. operates as a life sciences company. The firm develops proteomics platform for analyzing and quantifying the human proteome.

CEO

Sujal M. Patel

CEOSujal M. Patel

Employees

—

Employees—

Headquarters

Seattle, Washington

HeadquartersSeattle, Washington

Founded

2016

Founded2016

Employees

—

Employees—

NAUT Key Statistics

Market cap

259.30M

Market cap259.30M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

198.72K

Average volume198.72K

High today

$2.20

High today$2.20

Low today

$2.01

Low today$2.01

Open price

$2.10

Open price$2.10

Volume

102.30K

Volume102.30K

52 Week high

$6.59

52 Week high$6.59

52 Week low

$1.86

52 Week low$1.86

NAUT Earnings

-$0.19

-$0.13

-$0.06

$0.00

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 1, Pre-Market

ActualExpected Nov 1, Pre-Market

Nautilus Biotechnolgy

Why Robinhood?

Nautilus Biotechnology, Inc. operates as a life sciences company. The firm develops proteomics platform for analyzing and quantifying the human proteome. Show more

NAUT Key Statistics

Nautilus Biotechnology, Inc. operates as a life sciences company. The firm develops proteomics platform for analyzing and quantifying the human proteome.